All Practice Exams

200+ Free BCPS Practice Questions

Pass your Board Certified Pharmacotherapy Specialist exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
55-69% Pass Rate
200+ Questions
100% Free
1 / 200
Question 1
Score: 0/0

A 68-year-old male with community-acquired pneumonia is prescribed ceftriaxone and azithromycin. On day 3, his renal function deteriorates. Which adjustment is most appropriate?

A
B
C
D
to track
2026 Statistics

Key Facts: BCPS Exam

150

Total Questions

125 scored

3h 45m

Exam Time

BCPS format

500/800

Passing Score

Scaled scoring

36%

Patient Care Domain

Largest domain

$600

Exam Fee

BPS 2026

7 years

Certification Valid

Recertification cycle

The BCPS exam has a pass rate of approximately 55-69%. The exam uses 150 questions over 3 hours 45 minutes with scaled scoring (200-800, 500 passing). Content covers 16+ patient care specialty areas including infectious diseases, cardiology, critical care, and oncology. BCPS certification requires recertification every 7 years. Eligibility requires PharmD + active license + 3 years practice or PGY1 residency within 7 years.

Sample BCPS Practice Questions

Try these sample questions to test your BCPS exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 200+ question experience with AI tutoring.

1A 68-year-old male with community-acquired pneumonia is prescribed ceftriaxone and azithromycin. On day 3, his renal function deteriorates. Which adjustment is most appropriate?
A.Discontinue azithromycin and continue ceftriaxone alone
B.Switch to levofloxacin monotherapy
C.Discontinue ceftriaxone and continue azithromycin
D.Add vancomycin for broader coverage
Explanation: Azithromycin is primarily hepatically metabolized and does not require renal dose adjustment. Ceftriaxone can accumulate in renal impairment. For a patient improving on day 3 with acute kidney injury, discontinuing ceftriaxone and continuing azithromycin alone is appropriate. Fluoroquinolones and vancomycin would increase nephrotoxicity risk.
2Which antibiotic requires therapeutic drug monitoring to ensure efficacy and prevent toxicity?
A.Meropenem
B.Vancomycin
C.Piperacillin-tazobactam
D.Cefepime
Explanation: Vancomycin requires therapeutic drug monitoring (TDM) due to its narrow therapeutic index, variable pharmacokinetics, and risk of nephrotoxicity. Target trough concentrations are typically 10-15 mcg/mL for most infections and 15-20 mcg/mL for serious infections.
3A patient with complicated intra-abdominal infection is receiving ertapenem. Which pathogen is NOT adequately covered by this agent?
A.Escherichia coli
B.Bacteroides fragilis
C.Enterococcus faecalis
D.Klebsiella pneumoniae
Explanation: Ertapenem lacks coverage against Enterococcus species and Pseudomonas aeruginosa due to its inability to penetrate the outer membrane of these organisms. It provides coverage against most Enterobacteriaceae and anaerobes.
4Which combination represents the preferred empiric therapy for neutropenic fever in a patient with no prior history of antibiotic resistance?
A.Vancomycin plus cefepime
B.Meropenem alone
C.Cefepime or piperacillin-tazobactam
D.Vancomycin plus meropenem plus linezolid
Explanation: IDSA guidelines recommend monotherapy with an antipseudomonal beta-lactam (cefepime, piperacillin-tazobactam, or meropenem) as first-line empiric therapy for uncomplicated neutropenic fever. Vancomycin is reserved for specific indications like suspected catheter-related infection or known MRSA colonization.
5A patient with severe Clostridioides difficile infection is failing oral vancomycin. What is the next appropriate step?
A.Switch to oral metronidazole
B.Add intravenous vancomycin
C.Increase vancomycin dose and add intravenous metronidazole
D.Proceed directly to fecal microbiota transplantation
Explanation: For severe or fulminant C. difficile not responding to oral vancomycin, guidelines recommend adding IV metronidazole 500 mg every 8 hours and increasing oral vancomycin frequency to 500 mg every 6 hours. Fecal transplant is reserved for multiple recurrences.
6Which antiviral agent requires dose adjustment based on renal function for both treatment and prophylaxis of influenza?
A.Oseltamivir
B.Zanamivir
C.Peramivir
D.Baloxavir marboxil
Explanation: Oseltamivir is renally cleared and requires dose adjustment when CrCl is less than 30 mL/min. The dose should be reduced to 75 mg every other day for treatment or 75 mg every other day for prophylaxis in patients with severe renal impairment.
7A patient with endocarditis is receiving gentamicin synergy therapy. What is the primary target parameter for monitoring efficacy?
A.Peak concentration of 3-5 mcg/mL
B.Trough concentration less than 1 mcg/mL
C.Area under the curve (AUC)
D.24-hour urine collection
Explanation: For synergy dosing in endocarditis, gentamicin peak concentrations of 3-5 mcg/mL are targeted with extended-interval dosing (3 mg/kg daily). This provides optimal bacterial killing through concentration-dependent mechanisms.
8Which antifungal agent has the highest oral bioavailability and does NOT require an intravenous formulation for serious infections?
A.Voriconazole
B.Posaconazole
C.Fluconazole
D.Isavuconazonium
Explanation: Fluconazole has over 90% oral bioavailability, achieving the same serum concentrations as IV administration. This makes oral fluconazole appropriate for step-down therapy or initial treatment of susceptible infections in patients able to take oral medications.
9A patient with HIV presents with severe mucosal candidiasis refractory to fluconazole. Which antifungal is most appropriate for treatment?
A.Itraconazole
B.Voriconazole
C.Echinocandin (caspofungin, micafungin, or anidulafungin)
D.Terbinafine
Explanation: Echinocandins are first-line therapy for severe or refractory mucosal candidiasis, including azole-resistant strains. They have excellent activity against Candida species and minimal drug interactions compared to azoles.
10Which antibiotic is most likely to prolong the QT interval and should be avoided in patients with known long QT syndrome?
A.Azithromycin
B.Levofloxacin
C.Ceftriaxone
D.Both A and B
Explanation: Both macrolides (azithromycin) and fluoroquinolones (levofloxacin) can prolong the QT interval and increase risk of torsades de pointes. Both should be used cautiously in patients with baseline QT prolongation, hypokalemia, or concurrent use of other QT-prolonging agents.

About the BCPS Exam

The BCPS certification is a specialized credential for pharmacists who have advanced knowledge and skills in pharmacotherapy. The exam covers 3 major domains: Patient Care Specialty Areas (36%), Therapeutics and Patient Management (36%), and Professional Practice (28%). The exam consists of 150 items (125 scored, 25 unscored).

Questions

150 scored questions

Time Limit

3 hours 45 minutes

Passing Score

500/800 (scaled)

Exam Fee

$600 (Board of Pharmacy Specialties (BPS))

BCPS Exam Content Outline

36%

Patient Care Specialty Areas

Infectious Diseases, Cardiology, Nephrology, Pain Management, Endocrinology, Critical Care, Geriatrics, Pulmonology, Neurology, Emergency Medicine, Gastroenterology, Psychiatry, Oncology, Nutrition Support, Women's Health, Pediatrics, Allergy/Immunology

36%

Therapeutics and Patient Management

Treatment Planning (clinical assessment, pharmacokinetics, diagnosis), Therapeutic Implementation (pharmacotherapy, patient education, medication reconciliation), Treatment Outcomes and Monitoring (therapeutic targets, ADE management, adherence)

28%

Professional Practice

Quality of Care (public health, medication safety, ethics), Evidence-Based Practice (research methods, drug information), Practice Management (standards/regulations, pharmacoeconomics, quality management)

How to Pass the BCPS Exam

What You Need to Know

  • Passing score: 500/800 (scaled)
  • Exam length: 150 questions
  • Time limit: 3 hours 45 minutes
  • Exam fee: $600

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

BCPS Study Tips from Top Performers

1Master clinical pharmacokinetics and dosing adjustments for renal/hepatic impairment
2Know therapeutic drug monitoring parameters and target ranges for high-alert medications
3Study antimicrobial therapy including spectrum, resistance mechanisms, and stewardship
4Review cardiovascular pharmacology including anticoagulation, heart failure, and hypertension
5Understand evidence-based medicine concepts: NNT, NNH, relative vs absolute risk, study designs

Frequently Asked Questions

What is the BCPS pass rate?

The BCPS pass rate varies but typically ranges from 55-69% depending on preparation and experience. The exam uses scaled scoring from 200-800, with 500 required to pass. Scaled scoring accounts for question difficulty variations across exam forms.

How many questions are on the BCPS exam?

The BCPS exam contains 150 questions total, with 125 scored and 25 unscored pretest questions. You have 3 hours and 45 minutes to complete the exam.

What are the BCPS eligibility requirements?

To sit for the BCPS exam, you must have: (1) Graduated from an ACPE-accredited PharmD program, (2) Current, active pharmacist license, and (3) Either 3 years of clinical pharmacy practice OR completion of PGY1 pharmacy residency within the past 7 years.

How long is BCPS certification valid?

BCPS certification is valid for 7 years. Recertification can be achieved by either passing the exam again OR completing 100-120 hours of continuing education through BPS-approved programming.

What are the best study resources for BCPS?

Recommended BCPS study resources include: ACCP Clinical Practice Guidelines, DiPiro's Pharmacotherapy textbook, ACCP's PSAP modules, and practice questions. Plan for 3-6 months of study time. Focus on high-yield areas like infectious diseases, cardiology, critical care, and pharmacokinetics.

How should I prepare for the BCPS exam?

Study systematically across all domains: Patient Care Specialty Areas (36%), Therapeutics and Patient Management (36%), and Professional Practice (28%). Focus on clinical scenarios, pharmacotherapy decision-making, and evidence-based medicine. Complete at least 2000 practice questions.